Tucker Asset Management’s YieldMax MRNA Option Income Strategy ETF MRNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-23
Closed -$427 – 443
2026
Q1
$427 Hold
23
– – ﹤0.01% 369
2025
Q4
$338 Sell
23
-9
-28% -$144 ﹤0.01% 1008
2025
Q3
$565 Hold
32
– – ﹤0.01% 308
2025
Q2
$750 Sell
32
-1
-3% -$25 ﹤0.01% 287
2025
Q1
$914 Sell
33
-1
-3% -$38 ﹤0.01% 294
2024
Q4
$1.77K Hold
34
– – ﹤0.01% 1235
2024
Q3
$2.99K Hold
34
– – ﹤0.01% 1068
2024
Q2
$5.2K Buy
34
+5
+17% +$984 ﹤0.01% 1043
2024
Q1
$6.08K Buy
+29
New +$5.94K ﹤0.01% 1012

Other funds holding MRNY

Tucker Asset Management's MRNY Position: Q2 2026 in Review

Tucker Asset Management sold out of YieldMax MRNA Option Income Strategy ETF (MRNY) in Q2 2026, closing a stake of 23 shares — an estimated $427 sold.

Tucker Asset Management first reported a position in MRNY in Q1 2024 and held it in 9 quarters. The position peaked at $6.08K in Q1 2024. 10 funds tracked by Wall St. Rank hold MRNY as of Q2 2026.

  • Tucker Asset Management reported no remaining YieldMax MRNA Option Income Strategy ETF position as of Q2 2026 after selling out during the quarter.
  • Tucker Asset Management sold 23 YieldMax MRNA Option Income Strategy ETF shares in Q2 2026, an estimated $427.
  • Tucker Asset Management first reported a position in YieldMax MRNA Option Income Strategy ETF in Q1 2024 and held it in 9 quarters.
  • Tucker Asset Management's YieldMax MRNA Option Income Strategy ETF position peaked at $6.08K in Q1 2024.
  • 10 funds tracked by Wall St. Rank held YieldMax MRNA Option Income Strategy ETF as of Q2 2026.

Based on Tucker Asset Management's 13F filing for Q2 2026, filed 27 Aug 2026.